Selective sugar transport supports Proteus mirabilis fitness in the urinary tract.

Proteus mirabilis is a leading cause of complicated urinary tract infections (UTIs). Prior work showed P. mirabilis metabolizes sugars during experimental UTI, yet the role of sugar import systems in pathogenesis remains poorly defined. To investigate this, we generated a panel of 47 targeted mutants in predicted sugar transporter genes and assessed their growth in vitro and fitness in vivo. Growth screening in nutrient-rich and minimal media revealed carbon source-dependent defects in several phosphotransferase system (PTS) mutants, including ptsH and ptsI. Pooled insertion sequencing (In-seq) identified xapB, ptsH, and ptsI as in vivo fitness factors, with validation in a traditional murine co-challenge model. Functional studies showed that xapB, annotated as a xanthosine permease, did not support xanthosine or guanosine uptake in P. mirabilis, suggesting misannotation. Dissection of the PTS network revealed that a triple mutant lacking scrA, ulaC, and ptsG recapitulated the ptsH phenotype in vivo. To evaluate whether increased sugar availability exacerbates these defects, we modeled glucosuria using the SGLT2 inhibitor dapagliflozin in CBA/J mice. Dapagliflozin treatment significantly increased urinary glucose and enhanced P. mirabilis colonization. There was an inverse correlation between colonization and urinary glucose, but only in untreated mice. These findings reveal limitations in genome-based transporter annotation, establish a functional link between sugar import and P. mirabilis fitness during UTI, and demonstrate that host metabolic conditions such as glucosuria can influence the severity of infection.